Dealmakers newsletter: September 2008
Welcome to September's edition of the Dealmakers newsletter from CurrentPartnering.
Sponsored by: Intralinks | EuroPLX | DMS Data Systems
If not already signed up to receive our newsletters, do so here.
In this issue:
- Editor's corner
- NEW Partnering roundup
- Networks grows
- New partnering reports
- In the news - September 2008
- New best practice articles
- Forthcoming events
- Scorecards - newly updated with latest deals
- People on the move
- Partnering resources: Software tools
- Glossary of partnering terms
The Septmber issue of Dealmakers is sponsored by:
4th Modern Drug Discovery & Development Summit
October 15-17, 2008 – San Diego, CA, USA
The Modern Drug Discovery & Development Summit delivers a powerful package as the brightest minds in the pharmaceutical and biotechnological industries converge to share ideas and new developments in drug discovery. With 6 full conferences, 3 symposia and 6 mini sessions, the Modern Drug Summit addresses a wide variety of your needs. Networking opportunities abound at GTCbio’s exciting and innovative forum. Tracks include Translational Medicine, Emerging Targets & Therapeutics, Biological Therapeutics, Drug Design & Lead Discovery, Pharmacokinetics/Pharmacodynamics, and Partnering, Licensing & Deal-Making. Keynote presentations given by Keith James, SVP & Site Head, Pfizer, David Nicholson, SVP, Schering Plough and John Doll, Patents Commissioner, United States Patent & Trademark Office.
For further details visit the conference website
EDITOR'S CORNER
New this month, we have launched a monthly roundup of partnering related articles across the web. If you know of any interesting articles. drop us a line and will consider including in nex month's newsletter.
NETWORKS continues to grow - providing dealmakers with access to the CurrentPartnering Business Development Network at LinkedIn - join now - Networks
September has seen a limited number of partnering deals but lots of updates on existing partnerships as companies seek to maintain momentum, after a very quiet August. I am sure that autumn will continue to see a slowing of new deals, complemented by a number of updates of existing deals to fill the void.
We have been busy in our report publishing activities - our latest reports are now available
Discovery stage partnering agreements with biopharma
The report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies.
The report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies.
We have also made available Partnering Guides for each of the top 50 bigpharma companies. You can view a list of companies here.
The report adds to our growing portfolio of Agreements in Biopharma reports covering Clinical Stage Partnering Agreements in Biopharma, Co-promotion and Co-marketing, Merger and Acquisition, Manufacturing and Supply, Distribution, and Bigpharma.
You can also view the leading deals so far this year in our updated Scorecards.
Until next time - happy dealmaking!
- Steve Poile
NEW - PARTNERING ROUNDUP
The following are a list of articles of interest to business developers - updated monthly in this newsletter links working at time of publication
VC Funding for Biotech Companies Withering
AZ goes east for anticancer collaboration
Intellectual Property Business Models
Gilead may shoot past big firms' buyout hunts
Big pharma gravitates to the academe
Reverse mergers throw lifeline to struggling biotechs
Venture-backed cos. want piece of research pie
NETWORKS - community continues to grow!
Networks facilitates the connecting of business developers in biopharma through the use of social networkings tools - including LinkedIn, Facebook, Twitter and GoogleMaps.
To join or participate in CurrentPartnering's Network tools, just click on the link below for further details Networks - join now!
NEW PARTNERING REPORTS
Discovery Stage Partnering Agreements in Biopharma
The Discovery Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the discovery stage partnering agreements entered into by the worlds leading biopharma companies Discovery Stage Partnering Agreements in Biopharma report.
Partnering with Bigpharma
The report provides the most comprehensive and in-depth insight into the dealmaking interests and activity of the worlds leading fifty biopharma companies Partnering with Bigpharma
Individual Partnering Guides for each of the top 50 bigpharma companies - just $395 each
Pfizer - GlaxoSmithKline - Sanofi-Aventis - Novartis - AstraZeneca - Johnson & Johnson - Merck - Roche - Wyeth - Eli Lilly - Bristol-Myers Squibb - Mayer - Abbott - Amgen - Boehringer-Ingelheim - Schering-Plough - Takeda - Genentech - Teva - Novo Nordisk - Astellas - Daiichi Sankyo - Merck KGaA - Eisai - Otsuka - Servier - UCB - Baxter - Nycomed - Solvay - Gilead - Genzyme - Forest - Menarini - Allergan - Mitsubishi Tanabe - Chugai - Procter & Gamble - Ratiopharm - CSL - Barr - Alcon - Mundipharma - Shire - Biogen Idec - Stada - King - Lundbeck - Activis - Watson
Full list of top 50 companies covered
Clinical Stage Partnering Agreements in Biopharma
The Clinical Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the clinical stage partnering agreements entered into by the worlds leading biopharma companies Clinical Stage Partnering Agreements in Biopharma report.
Co-promotion & Co-marketing Agreements in Biopharma
The Co-promotion and Co-marketing Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies Co-promotion & Co-marketing Agreements in Biopharma
Also:
- Manufacturing and Supply Agreements in Biopharma
- Distribution Agreements in Biopharma
- Bigpharma Partnering Agreements
- Merger and Acquisition Agreements in Biopharma
- Practical Guide to Finding Partners in Biopharma
IN THE NEWS
The latest partnering developments - September 2008:
September saw a number of new partnership and M&A accouncements, including:
- Asterand to enter license deal with Allergan for pre-clinical compounds for eye disease
- Acucela and Otsuka enter co-development deal for ACU-4429 in dry age related macular degeneration
- Pfizer gains rights to Medivation Alzheimer's drug
- Shionogi to acquire Sciele Pharma for $1.4 billion
NEW BEST PRACTICE ARTICLES
Are Economics of Partnering Events Measurable? - Part 1
Procurement managers, accountants, and controllers sometimes have the impression that business development executives spend leisurely time in luxurious hotels and nice places just to have small talk with peers of other companies when they attend partnering conferences 'read more now <http://www.currentpartnering.com/articles/1351>`_
Intellectual Property Business Models
Here's something that you really should read if you're interested in the business of intellectual property read more here
FORTHCOMING EVENTS
Here is our suggested partnering events for the fall of 2008.
Pharmaceutical Strategic Alliances 2008
Marriott Financial Center, New York City, NY, USA - September 23-25, 2008
Meet the Most Important People in Dealmaking…The only conference that provides 100% case studies by CEOs and Senior Executives in the industry Pharmaceutical Strategic Alliances 2008
EuroPLX 37 Dresden
Dresden, Germany - October 6-7, 2008
Collaborative agreements in generics (incl. bio-generics and biosimilars), OTC drugs, and nutraceuticals EuroPLX 37 Dresden
4th Modern Drug Discovery & Development Summit
San Diego, CA, USA - October 15-17, 2008
The Modern Drug Discovery & Development Summit delivers a powerful package as the brightest minds in the pharmaceutical and biotechnological industries converge to share ideas and new developments in drug discovery - 4th Modern Drug Discovery & Development Summit
Therapeutic Area Partnerships 2008
Philadelphia, PA, USA - November 3-5, 2008
Windhover Information's 3rd Annual Therapeutic Area Partnerships is the industry's most targeted, efficient, and strategic-level partnering meeting for life science companies seeking partnerships in the top therapeutic areas: Oncology, Cardiovascular/Metabolic and Neuroscience Therapeutic Area Partnerships 2008
Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements
American Conference Institute's annual conference continues its tradition this year by bringing together key industry leaders and government representatives in order to discuss the critical issues impacting this ever changing landscape Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements
BioEurope 2008
Mannheim, Germany - November 17-19, 2008
The 14th annual BIO-Europe event is the world’s largest dedicated biotechnology partnering conference BioEurope 2008
SCORECARDS
Our scorecards have been updated with the latest deals to break into our most valuable deal rankings.
In addition, we have updated our top 25 bigpharma partnering activity scorecard for deals up to end August 2008.
- Partnering Top 20 - 2008
- Partnering Top 20 - 2007
- Partnering since 2000
- M&A Top 20 - 2008
- M&A Top 20 - 2007
- M&A since 2000
- Bigpharma Top 25 partnering - 2008
PEOPLE ON THE MOVE
The following people have been reported on the move during the weeks of August/September 2008:
Joe Ross, Brent Suen, Philip Theodore, Bill Arthur, Masanori Ueda, Peter Gonze, Juergen Lasowski to name just a few
read more about the latest people on the move
If you have news about a business development executive who is on the move - let us know
PARTNERING RESOURCES: SOFTWARE TOOLS
Numerous software tools exist to support the management and decision making in partnering - Software tools
GLOSSARY: UPDATED PARTNERING TERMS
The most recent addition is SPC or Supplementary Protection Certificate - a concession granted to pharma to extend protection under a patent more details
Full Glossary can be accessed here
Do you have specific glossary terms that you would like to see in our website? Give us your ideas here
CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers
Advertizing and sponsorship
CurrentPartnering offers several advertising options, enabling your product or service to be promoted to our global business development audience - further details available online.
or contact us to discuss your requirements.
Steve Poile, Editor
Web: http://www.CurrentPartnering.com
Mail: CurrentPartnering, Allanmere House, 6 Hobgate, York, YO24 4HF, United Kingdom
Tel: +44 7896 656732
Fax: +44 8703 305993
Scorecard Index
Deal term reports
The information you provide is excellent and we look forward to doing more business with you in the future
...You have published very timely and interesting materials.... I am excited.... It is an excellent publication and pretty well up to date...
CurrentPartnering Reports
The latest reports on best practise for dealmakers available from CurrentPartnering
Quick links
Term of the week...
Heads of agreement A pre-agreed document that outlines the key elements and structure of the planned deal.